| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 244.545 | 268.020 | - | 140.575 | 113.343 | 230.737 | 22.965 | 71.530 | 101.464 | 247.780 |
| Total Income - EUR | 246.527 | 323.676 | - | 162.894 | 157.272 | 240.142 | 47.233 | 72.610 | 105.616 | 252.477 |
| Total Expenses - EUR | 216.312 | 365.218 | - | 125.905 | 105.708 | 178.826 | 85.162 | 61.590 | 69.536 | 205.582 |
| Gross Profit/Loss - EUR | 30.215 | -41.541 | - | 36.988 | 51.564 | 61.315 | -37.930 | 11.019 | 36.080 | 46.894 |
| Net Profit/Loss - EUR | 24.175 | -44.361 | - | 35.359 | 50.052 | 59.101 | -38.402 | 10.302 | 35.085 | 39.759 |
| Employees | 1 | 1 | - | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
Check the financial reports for the company - Versus Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 131.796 | 968 | - | 0 | 0 | 5.710 | 4.025 | 2.475 | 909 | 22.954 |
| Current Assets | 259.761 | 190.075 | - | 158.634 | 142.897 | 161.038 | 32.137 | 79.082 | 101.371 | 86.086 |
| Inventories | 46.277 | 65.087 | - | 58.854 | 58.400 | 58.921 | 20.662 | 23.629 | 39.446 | 4.979 |
| Receivables | 161.166 | 66.944 | - | 80.749 | 38.233 | 50.344 | 10.707 | 53.021 | 58.340 | 72.245 |
| Cash | 52.318 | 58.044 | - | 19.030 | 46.264 | 51.774 | 768 | 2.433 | 3.585 | 8.863 |
| Shareholders Funds | 257.961 | 54.696 | - | 71.711 | 129.049 | 79.572 | -26.818 | -17.218 | 17.919 | 50.665 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 133.596 | 136.347 | - | 86.922 | 13.848 | 87.176 | 62.980 | 98.775 | 84.361 | 58.375 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Versus Med Srl